Lower Drug Costs for Low-Income Seniors on Medicare
This act aims to reduce prescription drug costs for low-income seniors enrolled in Medicare Part D. Starting in 2026, copayments for generic drugs will be eliminated, and copayments for other drugs will be frozen at 2023 levels, with minor inflation adjustments thereafter. This will lead to lower out-of-pocket expenses for seniors, potentially easing their financial burdens.
Key points
As of 2026, low-income individuals on Medicare Part D will pay $0 for generic drugs.
Copayments for other drugs will be frozen at 2023 levels, with small annual increases tied to inflation in subsequent years.
The act seeks to alleviate financial strain related to prescription drug purchases for seniors with limited incomes.
Introduced
Citizen Poll